| Literature DB >> 22005304 |
Alexandra M Ortiz1, Nichole R Klatt, Bing Li, Yanjie Yi, Brian Tabb, Xing Pei Hao, Lawrence Sternberg, Benton Lawson, Paul M Carnathan, Elizabeth M Cramer, Jessica C Engram, Dawn M Little, Elena Ryzhova, Francisco Gonzalez-Scarano, Mirko Paiardini, Aftab A Ansari, Sarah Ratcliffe, James G Else, Jason M Brenchley, Ronald G Collman, Jacob D Estes, Cynthia A Derdeyn, Guido Silvestri.
Abstract
CD4+ T cells play a central role in the immunopathogenesis of HIV/AIDS, and their depletion during chronic HIV infection is a hallmark of disease progression. However, the relative contribution of CD4+ T cells as mediators of antiviral immune responses and targets for virus replication is still unclear. Here, we have generated data in SIV-infected rhesus macaques (RMs) that suggest that CD4+ T cells are essential in establishing control of virus replication during acute infection. To directly assess the role of CD4+ T cells during primary SIV infection, we in vivo depleted these cells from RMs prior to infecting the primates with a pathogenic strain of SIV. Compared with undepleted animals, CD4+ lymphocyte-depleted RMs showed a similar peak of viremia, but did not manifest any post-peak decline of virus replication despite CD8+ T cell- and B cell-mediated SIV-specific immune responses comparable to those observed in control animals. Interestingly, depleted animals displayed rapid disease progression, which was associated with increased virus replication in non-T cells as well as the emergence of CD4-independent SIV-envelopes. Our results suggest that the antiviral CD4+ T cell response may play an important role in limiting SIV replication, which has implications for the design of HIV vaccines.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22005304 PMCID: PMC3204830 DOI: 10.1172/JCI46023
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808